Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Get the latest updates from Press releases directly as they happen.
Follow now 469 followers
Last updated 4 days ago
3 days ago
Marketing authorisation in EU expected by November 2024.
9 days ago
GSK confirmed it has reached two confidential settlements in cases filed in...
11 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials.
15 days ago
Granted based on results from phase III head-to-head DREAMM-7 trial.
16 days ago
Data support progression to phase III clinical trials.
16 days ago
GSK confirmed it has reached a settlement with Mr. Isaac Dixon, resolving...
16 days ago
Results show that GSK3943104 did not meet the study’s primary efficacy objective.
18 days ago
SWIFT-1 and SWIFT-2 phase III data show depemokimab delivered statistically significant and...
22 days ago
GSK announces positive headline results of MATINEE, the phase III clinical trial...
25 days ago
Presenting 56 abstracts to advance scientific understanding and support ambition to improve...
30 days ago
Authorisation helps protect this population for the first time ahead of this...
about 1 month ago
Designation expedites review of bepirovirsen as a potential treatment for people living...